|

Paclitaxel Polymeric Micelles for Injection Clinical Trials

3 actively recruiting trials

Pipeline

Phase 2: 1Phase 3: 2

Top Sponsors

  • Shanghai Yizhong Pharmaceutical Co., Ltd.2
  • Liu Huang1

Indications

  • Cancer3
  • Breast Cancer2
  • Metastatic Breast Cancer (MBC)1
  • Esophageal Carcinoma1
  • Pancreatic Cancer Metastatic1

Other3 trials

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer
Phase 2
Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer
Phase 3
Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.